-
Product Insights
MIG Real Estate – The Clarkson Apartments – Colorado
Equip yourself with the essential tools needed to make informed and profitable decisions with our MIG Real Estate - The Clarkson Apartments - Colorado report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Food Concepts/ MIG RE – Parmenter Street Redevelopment – Wisconsin
Equip yourself with the essential tools needed to make informed and profitable decisions with our Food Concepts/ MIG RE - Parmenter Street Redevelopment - Wisconsin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
BRO India – Ditte Dimme – Migging Road Upgrade – Arunachal Pradesh
Equip yourself with the essential tools needed to make informed and profitable decisions with our BRO India - Ditte Dimme - Migging Road Upgrade - Arunachal Pradesh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lepunafusp alfa in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Lepunafusp alfa in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )Drug Details:JR-171 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Travoprost in Open-Angle Glaucoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Travoprost in Open-Angle Glaucoma Drug Details: Travoprost is under development for the treatment of elevated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Travoprost in Ocular Hypertension
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Travoprost in Ocular Hypertension Drug Details: Travoprost is under development for the treatment of elevated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pabinafusp alfa in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Pabinafusp alfa in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )Drug Details:Pabinafusp Alfa (Izcargo) is  a recombinant fusion glycoprotein...
-
Product Insights
Innovations in Minimally Invasive Glaucoma Surgery (MIGS) Devices – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Minimally Invasive Glaucoma Surgery (MIGS) Devices - Global Pipeline Summary" provides comprehensive information about the Minimally Invasive Glaucoma Surgery (MIGS) Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Minimally Invasive Glaucoma Surgery (MIGS) Devices report provides key information and data related to: Extensive coverage of the Minimally Invasive Glaucoma Surgery (MIGS) Devices under development Review details of major...
-
Sector Analysis
Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
Glaucoma Surgery Devices Market Report Overview The glaucoma surgery devices market size was valued at $336.6 million in 2022. Glaucoma is an ocular disease that affects the optic nerve of the iris due to the fluid build-up in front of the eyes. It is one of the leading causes of vision loss and blindness globally. The risk for developing glaucoma increases with age and as the global population is aging the prevalence of glaucoma is also increasing globally. This will...
-
Product Insights
MIG Grp/ Royal Strategic/ Star Energy – Neutron Therapy Hospital – Abu Dhabi
Equip yourself with the essential tools needed to make informed and profitable decisions with our MIG Grp/ Royal Strategic/ Star Energy - Neutron Therapy Hospital - Abu Dhabi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
![]()
Net Present Value Model: Laronidase
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Laronidase Drug Details JR-171 is under...
-
Product Insights
![]()
Net Present Value Model: IzCargo
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model IzCargo Drug Details Pabinafusp Alfa (Izcargo) is  a...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – lepunafusp alfa
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry lepunafusp alfa Drug Details JR-171 is under development for the treatment of Hurler syndrome....
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – pabinafusp alfa
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pabinafusp alfa Drug Details Pabinafusp Alfa (Izcargo) is  a recombinant fusion glycoprotein produced by Chinese hamster...
-
Sector Analysis
Mongolia Insurance Industry – Key Trends and Opportunities to 2026
The Mongolia insurance market size was $85.4 million in 2021. The market is expected to grow at a CAGR of more than 10% from 2021 to 2026. The Mongolia insurance market research report provides a detailed outlook by product category for the Mongolian insurance industry. It provides values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability ratios, and premium by line of business, during the review period and forecast period. The report also...
-
Sector Analysis
Qatar 2021 – The New LNG Boom, World Cup 2022 Legacy, and the Opportunities and Challenges for Business – MEED Insights
Amid the challenges of the Covid-19 pandemic, the normalisation of relations between Doha and four of its Arab neighbours following a three-and-a-half-year diplomatic dispute is a breath of fresh air for Qatar's economy and society. It comes at an important time for the country. Over the past decade, the focus of Qatar’s investment has been on the development of the infrastructure needed to deliver the FIFA football World Cup in 2022, on the stadiums, the airports, rail and metro lines,...
-
Sector Analysis
Middle East Water, 2021 – Water and Wastewater Project and Investment Opportunities in the Middle East and North Africa – MEED Insights
While the Covid-19 pandemic has damaged prospects across many of the region’s traditional business sectors, it has boosted the outlook for water and wastewater investment in the Middle East and North Africa. In a region characterised by a lack of rivers, lakes and rainfall, water security has long been a priority, but the pandemic has refocused Middle East states on the vital importance of water security. GCC water demand is set to rise by about 62 per cent by 2025....
-
Thematic Analysis
![]()
Impact of India on Aerospace and Defense – Thematic Research
The impact of India is one of the emergent dominant trends in contemporary geopolitics The impact of India refers to the role of India as a major defense consumer and one of the world’s leading importers of defense products. This includes numerous attempts at incorporating and developing domestic production and/or assembly. The Modi government has prioritized the development of a robust domestic defense manufacturing base to curtail imports of expensive defense equipment. The government has changed procurement and FDI regulations...
-
Sector Analysis
Future of the Kazakh Defense Industry – Market Attractiveness, Competitive Landscape and Forecasts to 2023
The Future of Kazakh Defense Industry – Market Attractiveness, Competitive Landscape and Forecasts to 2023, published by Strategic Defense Intelligence, provides readers with detailed analysis of both historic and forecast defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Synopsis This report offers detailed analysis of Kazakh defense industry with market size forecasts covering the next five years. This report will also analyze factors that influence demand for the...
-
Sector Analysis
The Kazakh Defense Industry – Competitive Landscape and Strategic Insights to 2021: Market Profile
This report provides analysis on competitive benchmarking along with top companies active across the Kazakhstan defense industry. It features insights into the recent activity and strategic initiatives of key public sector companies that support the industry. The information is divided into sections such as company overview, products and services and alliances, to give the reader an understanding of the business environment in which the defense industry operates. SDI's "The Kazakh Defense Industry - Competitive Landscape and Strategic Insights to 2021:...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.